definiens: ( as such term is defined in the Share Purchase Agreement . No later than [ * * * ] ( [ * * * ] ) Business Days after Licensee ’s receipt of such notice, Licensee shall notify [COMPANY] whether Licensee wishes to enter intonegotiations with [COMPANY] to negotiate an agreement for Licensee to obtain the right corresponding to such ROFN Opportunity onreasonable commercial terms to be agreed on in good faith ( ) . If Licensee does not timely notify Ascendisthat it wishes to negotiate for the ROFN Opportunity, or notifies [COMPANY] that it is not interested in the ROFN Opportunity, Ascendisshall be free to engage with Third Parties discussions of such ROFN Opportunity, and Licensee shall have no further rights under thisClause 2.8 with respect to such ROFN Opportunity . If Licensee timely notifies [COMPANY] it wishes to negotiate an agreement for suchROFN Opportunity, the Parties shall enter into good faith negotiations not to exceed [ * * * ] ( [ * * * ] ) days with the goal of finalizing theterms of and executing such ROFN License Agreement . If after the expiration of such [ * * * ] ( [ * * * ] ) -day period ( the ), the Parties have not executed such ROFN License Agreement, [COMPANY] shall be free to engage with Third Partiesdiscussions of such ROFN Opportunity [ * * * ], and Licensee shall have no further rights under this Clause 2.8 with respect to suchROFN Opportunity . Notwithstanding any other provision of this Clause 2.8, in no event shall this Clause 2.8 limit in any way the abilityof [COMPANY] or its Affiliates to engage in discussions with a Third Party for [ * * * ] to such Third Party under the [COMPANY] PlatformTechnology to [ * * * ] commercialise an Endocrinology Product so long as such discussions are not in conflict with [COMPANY] ’s obligationsunder Clause 2.3(A ), and any such discussions shall not be deemed a for which this Clause 2.8 applies